Hostname: page-component-848d4c4894-sjtt6 Total loading time: 0 Render date: 2024-06-24T11:45:27.124Z Has data issue: false hasContentIssue false
  • English
  • Français

β-Amyloid Protein in Alzheimer's Disease

Published online by Cambridge University Press:  18 September 2015

Josephine Nalbantoglu
Josephine Nalbantoglu*
Affiliation:
Departments of Medicine, Neurology & Neurosurgery, McGill Center for Studies in Agin, McGill University, Montreal
*
Montreal Neurological Institute, 3801 University Street, Montreal, Quebec, Canada H3A 2B4
Rights & Permissions [Opens in a new window]

Abstract:

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

β-amyloid protein, a 42-43 amino acid polypeptide, accumulates abnormally in senile plaques and the cerebral vasculature in Alzheimer's disease. This polypeptide is derived from a membrane-associated precursor which has several isoforms expressed in many tissues. The precursor protein is processed constitutively within the P-amyloid domain, leading to the release of the large β-terminal portion into the extracellular medium, β-amyloid protein may be toxic to certain neuronal cell types and its early deposition may be an important event in the pathogenesis of Alzheimer's disease.

Type
Research Article
Information
Canadian Journal of Neurological Sciences , Volume 18 , Issue S3 , August 1991 , pp. 424 - 427
Copyright
Copyright © Canadian Neurological Sciences Federation 1991

References

REFERENCES

1.Glenner, GG, Wong, CW. Alzheimer’s disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 1984; 120: 885–890.CrossRefGoogle ScholarPubMed
2.Glenner, GG, Wong, CW. Alzheimer’s disease and Down’s syndrome: sharing of a unique cerebrovascular amyloid fibril protein. Biochem Biophys Res Commun 1984; 122: 1131–1135.CrossRefGoogle ScholarPubMed
3.Wong, CW, Quaranta, V, Glenner, GG. Neuritic plaques and cerebrovascular amyloid in Alzheimer disease are antigenically related. Proc Natl Acad Sci USA 1985; 82: 8729–8732.CrossRefGoogle ScholarPubMed
4.Masters, CL, Simms, G, Weinman, NA, et al. Amyloid plaque core protein in Alzheimer’s disease and Down’s syndrome. Proc Natl Acad Sci USA 1985; 82: 4245–4249.CrossRefGoogle Scholar
5.Kang, J, Lemaire, H-G, Unterbeck, A, et al. The precursor of Alzheimer’s disease amyloid A4 protein resembles a cell-surface receptor. Nature 1987; 325: 733–736.CrossRefGoogle ScholarPubMed
6.DeSauvage, F, Octave, J-N. A novel mRNA of the A4 amyloid pre–cursor gene coding for a possible secreted protein. Science 1989; 245: 651–653.CrossRefGoogle Scholar
7.Ponte, P, Gonzalez-DeWhitt, P, Schilling, J, et al. A new A4 amyloid mRNA contains a domain homologous to serine proteinase inhibitors. Nature 1988; 331: 525–527.CrossRefGoogle ScholarPubMed
8.Tanzi, RE, McClatchey, AI, Lamperti, ED, et al. Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer’s disease. Nature 1988; 331: 528–530.CrossRefGoogle ScholarPubMed
9.Kitaguchi, N, Takahashi, Y, Tokushima, Y, et al. Novel precursor of Alzheimer’s disease amyloid protein shows protease inhibitory activity. Nature 1988; 331: 530–532.CrossRefGoogle ScholarPubMed
10.Tanzi, RE, Gusella, JF, Watkins, PC, et al. Amyloid β-protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus. Science 1987; 235: 880–884.CrossRefGoogle ScholarPubMed
11.Oltersdorf, T, Fritz, LC, Schenk, DB, et al. The secreted form of the Alzheimer’s amyloid precursor protein with the Kunitz domain is protease nexin II. Nature 1989; 341: 144–147.CrossRefGoogle ScholarPubMed
12.Van Nostrand, WE, Cunningham, DD. Purification of protease nexin II from human fibroblasts. J Biol Chem 1987; 262: 8508–8514.CrossRefGoogle ScholarPubMed
13.Van Nostrand, WE, Wagner, SL, Suzuki, M, et al. Protease nexin-II, a potent anti-chymotrypsin, shows identity to amyloid-β protein precursor. Nature 1989; 341: 546.CrossRefGoogle Scholar
14.Smith, RP, Higuchi, DA, Broze, GJ. Platelet coagulation factor Xla-inhibitor, a form of Alzheimer amyloid precursor protein. Science 1990; 248: 1126–1128.CrossRefGoogle ScholarPubMed
15.Neve, RL, Finch, EA, Dawes, LR. Expression of the Alzheimer amyloid protein gene transcripts in the human brain. Neuron 1988; 1: 669–677.CrossRefGoogle ScholarPubMed
16.Palmert, MR, Golde, TE, Cohen, ML, et al. Amyloid protein precursor messenger RNAs: differential expression in Alzheimer’s disease. Science 1988; 241: 1080–1084.CrossRefGoogle ScholarPubMed
17.Johnson, SA, Rogers, J, Finch, CE. APP-695 transcript prevalence is selectively reduced during Alzheimer’s disease in cortex and hippocampus but not in cerebellum. Neurobiol Aging 1989; 10: 267–272.CrossRefGoogle ScholarPubMed
18.Johnson, SA, Pasinetti, GM, May, PC, et al. Selective reduction of the mRNA for the β-amyloid precursor protein that lacks a Kunitz-type protease inhibitor motif in cortex from Alzheimer brain. Exp Neurol 1988; 102: 264–268.CrossRefGoogle Scholar
19.Goedert, M. Neuronal localization of amyloid β-protein precursor mRNA in normal human brain and in Alzheimer’s disease. EMBOJ 1987; 6: 3627–3632.CrossRefGoogle ScholarPubMed
20.Johnson, SA, McNeill, T, Cordell, B, et al. Relation of neuronal APP-751/APP-695 mRNA ratio and neuritic plaque density in Alzheimer’s disease. Science 1990; 248: 854–856.CrossRefGoogle ScholarPubMed
21.Schmechel, DE, Goldgaber, D, Burkhart, DS, et al. Cellular localization of messenger RNA encoding amyloid β-protein messenger RNA in brains from patients with Alzheimer’s disease. Alzheimer Dis Assoc Disord 1988; 2: 96–111.CrossRefGoogle Scholar
22.Bahmanyar, S, Higgins, GA, Goldgaber, D, et al. Localization of amyloid β-protein messenger RNA in brains from patients with Alzheimer’s disease. Science 1987; 237: 77–80.CrossRefGoogle ScholarPubMed
23.Cohen, ML, Golde, TE, Usiak, MF, et al. Insitu hybridization of nucleus basalis neurons shows increased β-amyloid mRNA in Alzheimer disease. Proc Natl Acad Sci USA 1988; 85: 1227–1231.CrossRefGoogle Scholar
24.Higgins, GA, Lewis, DA, Bahmanyar, S, et al. Differential regulation of amyloid β-protein mRNA expression within hippocampal neuronal subpopulations in Alzheimer disease. Proc Natl Acad Sci USA 1988; 85: 1297–1301.CrossRefGoogle ScholarPubMed
25.Lewis, DA, Higgins, GA, Young, WG, et al. Distribution of precursor amyloid β-protein messenger RNA in human cerebral cortex: relationship to neurofibrillary tangles and neuritic plaques. Proc Natl Acad Sci USA 1988; 85: 1691–1695.CrossRefGoogle ScholarPubMed
26.Lemaire, HG, Salbaum, JM, Multhaup, G, et al. The preA4 (695) precursor protein of Alzheimer's disease A4 amyloid is encoded by 16 exons. Nucleic Acids Res 1989; 17: 517–522.CrossRefGoogle ScholarPubMed
27.Korenberg, JR, Pulst, SM, Neve, RL, et al. The Alzheimer amyloid precursor protein maps to human chromosome 21 bands q21.105–q21.05. Genomics 1989; 54: 124–127.CrossRefGoogle Scholar
28.Vitek, MP, Rasool, CG, deSauvage, F, et al. Absence of mutation in the β-amyloid cDNAs. Mol Brain Res 1988; 4: 121–131.CrossRefGoogle Scholar
29.Zain, SB, Salim, M, Chou, WG, et al. Molecular cloning of amyloid cDNA derived from mRNA expressed in the cortex. Proc Natl Acad Sci USA 1988; 85: 929–933.CrossRefGoogle ScholarPubMed
30.Tanzi, RE, Bird, ED, Latt, SA, et al. The amyloid β-protein is not duplicated in brains from patients with Alzheimer’s disease. Science 1987; 238: 666–669.CrossRefGoogle Scholar
31.Podlinsy, MB, Lee, G, Selkoe, DJ. Gene dosage of the amyloid β- precursor protein in Alzheimer’s disease. Science 1987; 238: 669–671.Google Scholar
32.Tanzi, RE, St George-Hyslop, PH, Haines, JL, et al. The genetic defect in Alzheimer’s disease is not tightly linked to the amyloid β-protein gene. Nature 1987; 329: 156–157.CrossRefGoogle ScholarPubMed
33.Van Broechkhoven, C, Genthe, AM, Vandenberghe, A, et al. Failure of familial Alzheimer’s disease to segregate with the A4–amyloid gene in several European families. Nature 1987; 329: 153–155.CrossRefGoogle Scholar
34.St. George-Hyslop, PH, Haines, JL, Farrer, LA, et al. Genetic linkage studies suggest that Alzheimer’s disease is not a single homogeneous disorder. Nature 1990; 347: 194–197.CrossRefGoogle Scholar
35.Levy, E, Carman, MD, Fernandez-Madrid, IJ, et al. Mutation of the Alzheimer’s disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science 1990; 248: 1124–1126.CrossRefGoogle ScholarPubMed
36.Weidemann, A, Konig, G, Bunke, D, et al. Identification, biogenesis, and localization of precursors of Alzheimer’s disease A4 amyloid protein. Cell 1989; 57: 115–126.CrossRefGoogle ScholarPubMed
37.Oltersdorf, T, Ward, PJ, Henriksson, T, et al. The Alzheimer amyloid precursor protein. Identification of a stable intermediate in the biosynthetic/degradative pathway. J. Biol Chem 1990; 265: 4492–4497.CrossRefGoogle ScholarPubMed
38.Sisodia, SS, Koo, EH, Beyreuther, K, et al. Evidence that β-amyloid protein in Alzheimer’s disease is not derived by normal processing. Science 1990; 248: 492–495.CrossRefGoogle Scholar
39.Esch, FS, Keim, PS, Beattie, EC, et al. Cleavage of amyloid β-peptide during constitutive processing of its precursor. Science 1990; 248: 1122–1124.CrossRefGoogle ScholarPubMed
40.Selkoe, DJ, Podlisny, MB, Joachim, CL, et al. β-amyloid precursor protein of Alzheimer disease occurs as 110-to 135-kilodalton membrane-associated proteins in neural and nonneural tissues. Proc Natl Acad Sci USA 1988; 85: 7341–7345.CrossRefGoogle ScholarPubMed
41.Palmen, MR, Podlisny, MB, Witker, DS, et al. The β-amyloid protein precursor of Alzheimer disease has soluble derivatives found in human brain and cerebrospinal fluid. Proc Natl Acad Sci USA 1989; 86: 6338–6342.Google Scholar
42.Podlisny, MB, Mamman, AL, Schlossmacher, MG, et al. Detection of soluble forms of the β-amyloid precursor protein in human plasma. Biochem Biophys Res Commun 1990; 167: 1094–1101.CrossRefGoogle ScholarPubMed
43.Davies, L, Wolska, B, Hilbich, C, et al. A4 amyloid protein deposition and the diagnosis of Alzheimer’s disease: prevalence in aged brains determined by immunocytochemistry compared with conventional neuropathology techniques. Neurology 1988; 38: 1688–1693.CrossRefGoogle ScholarPubMed
44.Rumble, B, Retallack, R, Hilbich, C, et al. Amyloid A4 protein and its precursor in Down’s syndrome and Alzheimer’s disease. New Engl J Med 1989; 320: 1446–1452.CrossRefGoogle ScholarPubMed
45.Giaccone, G, Tagliavini, F, Linoli, G, et al. Down patients: extracellular preamyloid deposits precede neuritic degeneration and senile plaques. Neurosci Lett 1989; 97: 232–238.CrossRefGoogle ScholarPubMed
46.Mann, DMA, Brown, A, Prinja, D, et al. An analysis of the morphology of senile plaques in Down’s syndrome patients of different ages using immunocytochemical and lectin histochemical techniques. Neuropathol Appi Neurobiol 1989; 15: 317–329.CrossRefGoogle ScholarPubMed
47.Van Duinen, SG, Castano, EM, Prelli, F, et al. Hereditary cerebral hemorrhage with amyloidosis in patients of Dutch origin is related to Alzheimer disease. Proc Natl Acad Sci USA 1987; 84: 5991–5994.CrossRefGoogle ScholarPubMed
48.Yankner, BA, Caceres, A, Duffy, LK. Nerve growth factor potentiates the neurotoxicity of β amyloid. Proc Natl Acad Sci USA 1990; 87: 9020–9023.CrossRefGoogle ScholarPubMed
49.Yankner, BA, Dawes, LR, Fisher, S, et al. Neurotoxicity of a fragment of amyloid precursor associated with Alzheimer’s disease. Science 1989; 245: 417–420.CrossRefGoogle ScholarPubMed